Psychosomatic Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richards, M.
Right arrow Articles by Wadsworth, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richards, M.
Right arrow Articles by Wadsworth, M.
Related Collections
Right arrow Pulmonary
Right arrow Cognitive Functioning
Psychosomatic Medicine 67:602-608 (2005)
© 2005 American Psychosomatic Society


ORIGINAL ARTICLES

Lung Function and Cognitive Ability in a Longitudinal Birth Cohort Study

Marcus Richards, PhD, David Strachan, MD, Rebecca Hardy, PhD, Diana Kuh, PhD and Michael Wadsworth, PhD

From the MRC National Survey of Health and Development, University College London, U.K. (M.R., R.H., D.K., M.W.); and the Department of Public Health Sciences, St. George’s Hospital Medical School, London, U.K. (D.S.).

Address correspondence and reprint requests to Marcus Richards, PhD, University College London, Department of Epidemiology & Public Health, 1–19 Torrington Place, London WC1E 6BT, U.K. E-mail: m.richards{at}ucl.ac.uk


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Objective: The objective of this study was to examine the association between forced expiratory volume in 1 second (FEV1) and cognitive ability in midlife in the normal population.

Methods: Multiple regression was used to test associations between FEV1 and cognitive function in 1778 men and women in the MRC National Survey of Health and Development, also known as the British 1946 birth cohort. Analyses were adjusted for sex, body size (birth weight, adult height, weight, and chest circumference), socioeconomic status, lifetime smoking, and a range of health indicators, including early respiratory vulnerability (infant lower respiratory infection, childhood asthma, and exposure to atmospheric pollution).

Results: FEV1 at 43 years was associated with slower psychomotor speed (peg placement) at the same age and with slower decline in psychomotor speed (letter search speed) from 43 to 53 years, independently of the previously mentioned potential confounders. These independent associations were not observed, however, for adult verbal ability, verbal memory, or rate of decline in memory, which were significantly explained by socioeconomic status and adolescent cognitive ability. In a subsequent analysis, adolescent cognition was positively associated with FEV1, although not with rate of decline in FEV1 from 43 to 53 years, again independently of the previously mentioned confounders.

Conclusions: Cognitive function and FEV1 are positively associated across the life course. One possible explanation lies in the parallel action of endocrine, autonomic, and motor control systems on respiration and higher mental function. Because respiration and mental function are both associated with functional capacity and survival, this is a matter of potential clinical significance.

Key Words: lung function • cognitive function • birth cohort

Abbreviations: AH4 = Alice Heim group abilities test; COPD = chronic obstructive pulmonary disease; FEV1 = forced expiratory volume within 1 second; FVC = forced vital capacity; NSHD = National Survey of Health and Development; NART = National Adult Reading Test; SES = socioeconomic status.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Severallines of evidence indicate that lung function is associated with cognitive performance. Patients with chronic obstructive pulmonary disease (COPD) show slowed electrocortical activity (1,2) and impaired cognitive function (3,4). Conversely, cognitive function is improved after stabilization of circadian variation in ventilatory flow in asthmatics (5). The association between respiratory and cognitive function is also observed in the normal population in cross-sectional (6–8) and longitudinal (9–11) studies, in which, to varying degrees, relevant demographic, socioeconomic, and health-related confounders are controlled. This link between respiratory and cognitive function is of clinical importance, because decreased pulmonary function is associated with increased risk of dementia in the population, even after controlling for COPD (12), and pulmonary and cognitive function are both associated with survival (13,14).

In terms of underlying mechanisms, the most widely held view is that impaired lung function causes changes in the central nervous system (CNS) through possible processes such as vascular disease resulting from inflammation, impaired fibrinolytic activity, oxidative stress or cardiovascular risk factors (see 15), or hypoxia-induced changes in neurotransmitter metabolism (16). Such CNS changes then lead to lower cognitive function. However, given that respiratory control requires the operation of brain structures across many levels of the neuraxis (17), it may be that cognitive function is a marker of the general integrity of neurorespiratory regulation. If so, the association between respiration and cognition may be evident at an earlier stage of the life course.

The British 1946 birth cohort study has measured pulmonary function in midlife before lung disease has had a major impact on survival. We investigated the association between lung function and cognition at 43 years, and between lung function at this age and change in cognitive function from 43 to 53 years, controlling for a range of sociodemographic, socioeconomic, and health-related indicators. We then investigated the association between childhood cognition and adult lung function and change.


    METHODS AND MATERIALS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Study Participants
Participants were drawn from the MRC National Survey of Health and Development (NSHD), a birth cohort study stratified by social class and initially consisting of 5362 people selected from all births that occurred in England, Scotland, and Wales during 1 week in March 1946 (18). Information about sociodemographic factors and medical, cognitive, and psychological function has been repeatedly obtained by interview and examination, most recently in 1999 at age 53 years, when sample size was 3035. At this time, the cohort was shown still to be a representative sample, in most respects, of the U.K. population legitimately and singly born in the immediate postwar era (19). Exceptions were an overrepresentation among nonresponders of those never married and those least advantaged in terms of cognitive ability, educational attainment, and social class. Ethical approval for this study came from the North Thames Multicenter Research Ethics Committee.

Lung Function
Lung function was represented by forced expiratory volume in 1 second (FEV1) measured at 43 years and 53 years using a Micro Medical Micro Plus spirometer, administered by a trained nurse. On both occasions, participants were asked to stand, fill their lungs to capacity, make an airtight seal around the mouthpiece with their lips, then blow as hard and fast as possible until their lungs were empty. Participants did not wear a noseclip. The nurse first demonstrated the technique and then provided verbal encouragement during the trials. Three trials were given at 43 years, and 2 trials were given at 53 years. The higher value of the first 2 trials, and of either trial, respectively, was used for analysis. When the survey member’s spirometer technique at 53 years was rated as unsatisfactory by the nurse, values for that trial were classified as missing data. Nine survey members were excluded from the analysis because their technique was unsatisfactory on both trials. These nurse ratings were not undertaken at 43 years. Variation in FEV1 across both trials was within 5% for 77.5% of the sample at 43 years and 79.6% of the sample at 53 years.

Adult Cognitive Measures
At 43 years, they were given a timed peg placement test (overall mean of 3 trials for each hand subjected to a log transformation to improve distribution), and at 43 and 53 years, they were given repeat tests of memory (a 3-trial 15-item word list), and speed and concentration (timed letter search). A different word list was given to each half of the cohort at 43 years, and then these lists were reversed at 53 years. Target letters were in different positions on the page at 43 and 53 years. At age 53, they also took the National Adult Reading Test (NART) (20), a test of verbal ability requiring the pronunciation of 50 irregular words of increasing difficulty. All cognitive measures were administered after appropriate training to the nurses.

Potential Confounding Variables
Body size is a potential confounder because birth weight is associated with ventilatory function (21), because FEV1 increases with height, and because pre- and postnatal growth is associated with cognitive function (22,23). The following parameters were used: birth weight, adult leg length, trunk length, expanded chest circumference, and weight current to FEV1 at 43 years. Adult standing height was measured at 53 years to the nearest 0.5 cm using a portable stadiometer, as was sitting height (to represent trunk length). Leg length was calculated as the difference between sitting and standing height. Expanded chest circumference was also measured at 53 years in men at nipple level and in women immediately below the breasts.

Socioeconomic status (SES) was represented by father’s social class, mother’s education, material home conditions, own educational attainment, and own current or last occupational social class at 43 years. An aggregate variable representing material home conditions at age 4 years comprised ratings by a health visitor of age, cleanliness, and state of repair of the dwelling; number of people per room; and cleanliness and condition of clothing and shoes of the survey member. This total score was then categorized into very good, good, modest, or poor (24). For own educational attainment, the highest educational qualifications and their training equivalents attained by 26 years were classified as none, vocational only, ordinary secondary (O levels), advanced secondary (A levels), or degree level or equivalent. Social class was classified as professional, managerial, intermediate, skilled manual, semiskilled manual, or unskilled, according to the Registrar General.

Smoking impairs FEV1 and is associated with cognitive decline (25). Information on daily cigarette consumption was obtained at ages 20, 25, 31, 36, 43, and 53 years. A measure of lifetime smoking to 43 years was calculated by multiplying pack-years at each age by the number of years to the next age (e.g., smoking exposure from 25–31 years was calculated as pack-years at 25 multiplied by 6), and then totalling and averaging these products. To include adolescent smoking, pack-years at 20 years was multiplied back to 16 years.

Other health-related measures at 43 years such as physical exercise, which is protective of cognitive decline (26), was classified as 0, 1 to 4, or 5+ sporting or recreational activities per month based on an equivalent scheme for activities at 36 years (27). Resting pulse and systolic and diastolic blood pressure were measured by a research nurse. Significant respiratory problems were classified by self-reports of any of the following: a wheezy or whistling chest most days or nights, usually bringing up phlegm or coughing in the morning or during the day or night in winter for at least 3 months each year, or any chest illness (e.g., bronchitis, pneumonia) that required sickness absence of a week or more. Affective state was measured by the Psychiatric Symptom Frequency (PSF) scale (28).

Information on lower respiratory infection in infancy, which is a risk factor for adult respiratory problems (29,30), was provided by the respondents’ mothers. A small number of survey members (n = 58) had also been noted as having asthma by a school doctor at 6, 11, or 15 years. Because this cohort was born 10 years before the Clean Air Act of 1956, exposure to air pollution from incomplete coal combustion from birth to 9 years, estimated from validated measures (31), was also used as a potential confounder.

To investigate a possible neurodevelopmental pathway to lung function, the effect of adjusting for cognitive ability at 15 years was examined. At this age, children took the Heim AH4 test (32), the Watts-Vernon Reading Test (33), and a mathematics test. The AH4 is a 130-item ability test, with verbal items (analogies, comprehension, and numerical reasoning) and nonverbal items (matching, spatial analysis, and nonverbal reasoning) summed to yield a general ability score. The Watts-Vernon is a test of reading comprehension, requiring selection of appropriate words to complete 35 sentences. The mathematics test consisted of 47 items, requiring the use of arithmetic, geometry, trigonometry, and algebra. Concerning reliability of these tests, Pidgeon (33) quoted a figure of 0.92 for test–retest consistency of the total AH4 score with an interval of 1 month, a figure of 0.89 for reliability of the Watts-Vernon reading test as calculated from the Kuder-Richardson Formula 20 test, and noted a similar figure for test–retest analysis.

Scores for these three tests were summed to obtain an overall score representing general cognitive ability. This score was normally distributed within the present study sample.

Statistical Analysis
The association between FEV1 at 43 and midlife cognitive function was tested using memory, search speed, and peg placement speed at 43 years, and the NART at 53 years as outcomes. Conditional models of change were used to investigate the association between FEV1 at 43 and change in memory and search speed from 43 to 53 years, adjusting the memory and search speed scores at 53 years for their corresponding scores at 43 years. These analyses were performed in stages, controlling for sex and body size (model 1), then SES (model 2), then lifetime smoking (model 3), and then cognition at 15 years (model 4). We then tested the association between cognitive ability at 15 years and FEV1 at 43 years, and, also using conditional analysis of change, rate of FEV1 decline from 43 to 53 years, similarly adjusting for covariates in stages, according to models 1 to 4.

For all analyses, FEV1, the age 15 cognitive ability score, lifetime smoking, and all body size parameters were entered as continuous variables, whereas education and social class were entered as categorical variables.

Finally, all stage 4 models were adjusted for each remaining health indicator in turn, i.e., physical exercise, pulse, blood pressure, adult lung disease, affective state (PSF), infant lower respiratory infection, childhood asthma, and atmospheric pollution.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Sample Size
Of the 3035 cohort members who provided information at 53 years, 1778 had nonmissing data for FEV1 at 43 and 53 years, all cognitive variables, parental and adult SES, all body size parameters, and smoking. Those with missing data for any of these variables had lower cognitive ability in childhood (p < .001).

Forced Expiratory Volume in 1 Second and Midlife Cognition
Tables 1 to 3 show regression coefficients and 95% confidence intervals representing mean increase in peg placement time at 43 years and verbal ability (NART) at 53 years, and mean difference (change) in memory and search speed for given memory and search speed scores at 43 years, per unit increase in FEV1 at 43 years, in which positive coefficients represent slower decline. These associations were adjusted for sex and body size (model 1), then SES (model 2), then lifetime smoking (model 3), and then cognitive ability at 15 years (model 4).


View this table:
[in this window]
[in a new window]
 
TABLE 1. Regression Coefficients and 95% Confidence Intervals Representing Mean Difference in Peg Placement Speed and NART Score Per Unit Increase in Forced Expiratory Volume in 1 Second at 43 Years, Progressively Adjusting for Sex and Body Size, Socioeconomic Status, Smoking, and Adolescent Cognitive Ability (n = 1778)

 


View this table:
[in this window]
[in a new window]
 
TABLE 2. Regression Coefficients and 95% Confidence Intervals Representing Mean Difference in Memory at 43 Years, and Rate of Change in Memory From 43 to 53 Years, per Unit Increase in FEV1 at 43 Years Progressively Adjusting for Sex and Body Size, SES, Smoking, and Adolescent Cognitive Ability (n = 1778)

 


View this table:
[in this window]
[in a new window]
 
TABLE 3. Regression Coefficients and 95% Confidence Intervals Representing Mean Difference in Search Speed at 43 Years, and Rate of Change in Search Speed From 43 to 53 Years, per Unit Increase in FEV1 at 43 Years, Progressively Adjusting for Sex and Body Size, SES, Smoking, and Adolescent Cognitive Ability (n = 1778)

 
FEV1 was positively associated with peg placement speed (model 1) in that a negative coefficient represented faster task completion time with better lung function. The strength of this association was unaffected by adjusting for SES, smoking, or adolescent cognitive ability (models 2–4).

Although FEV1 was strongly associated with the NART at 53 years with sex- and body size-adjusted (model 1), the strength of this association was greatly reduced after controlling for SES. The coefficient was essentially unchanged by subsequent control for lifetime smoking. Indeed, when smoking was added to model 1 without adjustment for SES, FEV1 was still strongly associated with the NART (p < .001). However, the association was further reduced by control for adolescent cognitive ability (model 4), after which it was no longer significant at the 5% level. Adding adolescent cognitive ability to the model substantially reduced the strength of association between SES and the NART (not shown), and therefore accounted for a significant proportion of its effect.

A similar pattern to that for the NART was observed for verbal memory at 43 years. The association was positive and significant with only sex and body size in the model (Table 2, model 1), but was also strongly reduced after controlling for SES and lifetime smoking. Smoking added to model 1 by itself reduced the association, although the effect of FEV1 remained highly significant (p < .001). Again, the association was further reduced by controlling for adolescent cognitive ability (model 4), after which it was no longer significant at the 5% level. Higher FEV1 was weakly associated with slower rate of decline in memory from 43 to 53 years, although this effect was reduced to nonsignificance after controlling for SES and smoking (p = .24 for smoking added to model 1 alone), and almost completely attenuated after further control for adolescent cognition. Again, age 15 cognition explained to a significant extent the association between SES and verbal memory, and, indeed, reduced the associations between FEV1 and memory to nonsignificance when entered without SES or smoking (p = .08 and .50 for memory at 43 years and change in memory from 43 to 53 years, respectively).

Whereas FEV1 was not associated with search speed at 43 years (Table 3), higher FEV1 was associated with slower rate of decline from 43 to 53 years in this measure, even after adjustment for sex, body size, SES, smoking, and adolescent cognition (models 2–4). The strength of the association for search speed change in model 4 was not significantly altered by further control for peg placement time (p = .01), suggesting that FEV1 is associated with the cognitive (e.g., attentional) component of the visual search task, as well as with the motor speed component.

None of these model 4 associations were significantly altered by further adjustment, in turn, for infant lower respiratory infection, childhood asthma, early exposure to atmospheric pollution, adult lung disease, engagement in physical exercise, resting pulse, systolic or diastolic blood pressure, or affective state (not shown).

Cognitive Ability at 15 Years and Midlife Forced Expiratory Volume in 1 Second
Because of the significant effect on most of the previously mentioned associations of adjusting for adolescent cognitive ability, the association between adolescent cognitive ability and midlife FEV1 was itself investigated. Table 4 shows regression coefficients and 95% confidence intervals representing mean difference in FEV1 at 43 years per unit increase in ability at 15 years, progressively adjusting for sex and body size, SES, and smoking.


View this table:
[in this window]
[in a new window]
 
TABLE 4. Regression Coefficients and 95% Confidence Intervals Representing Mean Increase in FEV1 At 43 Years per Unit Increase in Ability at 15 Years, Progressively Adjusting for Sex and Body Size, SES, and Smoking (n = 1778)

 

It can be seen that ability at 15 years was positively associated with FEV1 after adjusting for sex and body size (model 1). The strength of this association was reduced after adjusting for SES and lifetime smoking, although it remained significant at the 5% level throughout. Smoking added to model 1 alone reduced the association (p < .001), although not by as much as SES. When the cognitive ability score was divided into fifths, the difference in mean FEV1 between the lower and upper fifths, adjusted for all covariates, was 0.49 L, in which mean overall FEV1 was 2.95 L. This is illustrated in Figure 1.



View larger version (21K):
[in this window]
[in a new window]
 
Figure 1. FEV1 at 43 years by cognitive ability at 15 years (adjusted for sex, body size, SES, and smoking).

 

Table 5 shows regression coefficients representing the association between cognitive ability at 15 years and rate of decline in FEV1 from 43 to 53 years, in which positive associations represent slower decline. Higher ability at 15 years was associated with slower decline in FEV1 after adjusting for sex and body size (model 1). This association was reduced to nonsignificance by control for SES (model 2), although not when smoking was entered without SES (p = .01).


View this table:
[in this window]
[in a new window]
 
TABLE 5. Regression Coefficients and 95% Confidence Intervals Representing Mean Difference in Rate of FEV1 Decline From 43 to 53 Years per Unit Increase in Ability at 15 Years, Progressively Adjusting for Sex and Body Size, SES, and Smoking (n = 1778)

 

Like with FEV1 and adult cognition, none of these model 3 associations for childhood ability were significantly altered by further adjustment, in turn, for infant lower respiratory infection, childhood asthma, early exposure to atmospheric pollution, adult lung disease, engagement in physical exercise, resting pulse, systolic or diastolic blood pressure, or affective state (not shown).

When FEV1/FVC (forced vital capacity) ratio was substituted for FEV1, this adjusted ratio was significantly associated with peg placement time (p = .006) and rate of decline in search speed (p = .01). However, associations between childhood IQ and this ratio at 43 years, and between change in this ratio from 43 to 53 years were not significant at the 5% level. This may be because FVC is less accurately measured by the Micro Medical spirometer than FEV1.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
In a large prospective birth cohort study, we found that FEV1 at 43 years was associated with slower psychomotor speed (peg placement) at the same age, and with slower decline in psychomotor speed (letter search speed) from 43 to 53 years, independently of body size, SES, lifetime cigarette smoking, early respiratory vulnerability, adult lung disease, physical exercise, pulse, blood pressure, and affective state. These independent associations were not observed, however, for adult verbal ability, verbal memory, or rate of decline in memory. Indeed, associations between FEV1 and these latter measures were largely explained by SES and adolescent cognition.

In a further series of analyses, we also found that cognitive ability at 15 years was positively associated with FEV1 at 43 years, also independently of the previously mentioned potential confounders, although not with change in FEV1 from 43 to 53 years, which was largely explained by SES. This possibly implies a neurodevelopmental pathway that predicts growth but not decline in lung function.

Principal strengths of this study are the availability of cognitive measures across the life course, repeated measures of FEV1 in midlife, and the range of potential confounders noted here. Two limitations, however, should be noted. First, there was a disproportionate loss to follow up of those with lower cognitive ability, a familiar problem in studies of cognitive aging. This bias limits generalizability of our findings, and may have led to underestimation of the strength of association between cognition and FEV1. Second, although we were able to control for a wide range of confounders, we were not, at this time, able to adjust for nutrients of potential importance for cognition and for lung function such as antioxidant vitamins (34). Such data will be available for future analysis.

With these strengths and weaknesses in mind, what might underlie the association between cognitive function and lung function? There are several psychosocial factors of potential significance, including the role of motivation and compliance, although the association was not confounded by affective state. It also seems unlikely that it was explained by varying ability to follow instructions. This might have resulted in an inverse J-shaped curve, with markedly poorer ventilatory function in those of lowest ability, but is unlikely to have produced the observed linear trend between cognition at 15 and adult lung function.

At the biologic level, it is sometimes assumed that changes in lung function alter cerebral oxygenation. This is plausible for those with severe lung disease such as hypoxemic COPD, although controlling for self-reported lung disease in this study did not significantly alter our results. In healthy individuals, however, homeostatic mechanisms to maintain stable cerebral oxygen levels are highly effective. For example, PO2 and brain blood flow remain constant during exercise even in the face of massive increase in cardiac output (35,36). There is a strong linkage between cerebral blood flow and neurometabolism that is regionally precise. For example, complex cognitive activity produces an increase in flow to several brain regions, but this involves redistribution, whereas whole-brain metabolic rate and blood flow remain constant (37). A different possibility is that low FEV1 is a risk factor for cerebral infarction and white matter lesions, which in turn are associated with cognitive decline. Although there is evidence for both of these propositions (15,38,39), this evidence comes from studies of older people, and controlling for blood pressure (hypertension being a risk factor for cerebral vascular disease (40)) did not alter the association between FEV1 and cognition in this middle-aged sample.

An intriguing clue as to the nature of the association between lung function and cognition is that we found cognitive ability in adolescence to be specifically associated with FEV1, possibly reflecting a neurodevelopmental pathway to adult lung function. Given that respiratory control requires the operation of brain structures across many levels of the neuraxis (17), it may be that cognitive function is a marker of the general integrity of the neurorespiratory system. From this perspective, lung and cognition function, rather than having a causal relationship, may simply covary across the life course according to common regulatory processes. This echoes, from a developmental perspective, the common-cause theory of aging (41). Unfortunately, ventilatory function was not measured in childhood, and so we cannot confirm whether the association between FEV1 and cognition was already present at this stage of the life course. This seems a reasonable possibility, however, in view of evidence that ventilatory and cognitive function both track across the life course (42,43).

In terms of normal function, there are, in fact, numerous candidates for such common processes, i.e., biochemical aspects of respiratory control that are also involved in higher mental function. These include the hormones estrogen and thyroid, all of the major monoamines (acetylcholine, dopamine, noradrenaline, and serotonin), the amino acid GABA, and a range of neuropeptides (44). A further possibility concerns the role of the hypothalamic–pituitary–adrenal (HPA) axis. In rats, prenatal dexamethasone affects the development of many organ systems, including the lung (45), and in humans, cortisol, which in excess is capable of damaging neural structures important for cognition (46), was found to be negatively associated with lung function in the MacArthur Studies of Healthy Aging (9). Of possible relevance in this context, rate of decline in psychomotor speed, which was slower in the present study with increasing FEV1, was exacerbated by early emotional adversity in this cohort (24); indeed, the outstanding long-term cognitive effect of this exposure. Glucocorticoids also regulate insulin-like growth factors during development (47,48) that target areas of the brain important for cognition as well as determining physical growth (49). With the caveat that the association between lung function and cognition in our study was not explained by body size, our finding of an association between cognition during the developmental years and lung function is consistent with the early effects of these control systems. These matters deserve further investigation.


    NOTES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

The National Survey of Health and Development is funded by the Medical Research Council. Data collection at 53 years was carried out by the National Centre for Social Research.

DOI:10.1097/01.psy.0000170337.51848.68


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS AND MATERIALS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

  1. Reeves RR, Struve FA, Patrick G, Payne DK, Thirstrup LL. Auditory and visual P300 cognitive evoked responses in patients with COPD: relationship to degree of pulmonary impairment. Clin Electroencephalogr 1999;30:122–5.[Medline]
  2. Reeves RR, Struve FA, Patrick G, Payne DK, Thirstrup LL. Topographic quantitative analysis of the intrinsic alpha rhythm in chronic obstructive pulmonary disease. Clin Electroencephalogr 2000;31:141–4.[Medline]
  3. Stuss DT, Peterkin I, Guzman DA, Guzman C, Troyer AK. Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures. J Clin Exp Neuropsychol 1997;19:515–24.[Medline]
  4. Incalzi RA, Chiappini F, Fuso L, Torrice MP, Gemma A, Pistelli R. Predicting cognitive decline in patients with hypoxaemic COPD. Respir Med 1998;92:527–33.[CrossRef][Medline]
  5. Weersink EJ, van Zomeren EH, Koeter GH, Postma DS. Treatment of nocturnal airway obstruction improves daytime cognitive performance in asthmatics. Am J Respir Crit Care Med 1997;156:1144–50.[Abstract/Free Full Text]
  6. Cook NR, Evans DA, Scherr PA, Speizer FE, Vedal S, Branch LG, Huntley JC, Hennekens CH, Taylor JO. Peak expiratory flow rate in an elderly population. Am J Epidemiol 1989;130:66–78.[Abstract/Free Full Text]
  7. Emery CF, Huppert FA, Schein RL. Do pulmonary function and smoking behaviour predict cognitive function? Findings from a British sample. Psychol Health 1997;12:265–75.[CrossRef]
  8. Cerhan JR, Folsom AR, Mortimer JA, Shahar E, Knopman DS, McGovern PG, Hays MA, Crum LD, Heiss G. Correlates of cognitive function in middle-aged adults. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Gerontology 1998;44:95–105.[CrossRef][Medline]
  9. Albert MS, Jones K, Savage CR, Berkman L, Seeman T, Blazer D, Rowe JW. Predictors of cognitive change in older persons: MacArthur Studies of Successful Aging. Psychol Aging 1995;10:578–89.[CrossRef][Medline]
  10. Chyou PH, White LR, Yano K, Sharp DS, Burchfiel CM, Chen R, Rodriguez BL, Curb JD. Pulmonary function measures as predictors and correlates of cognitive functioning in later life. Am J Epidemiol 1996;143:750–56.[Abstract/Free Full Text]
  11. Emery CF, Pedersen NL, Svartengren M, McClearn GE. Longitudinal and genetic effects in the relationship between pulmonary function and cognitive performance. J Genrontol 1998;53B:P311–17.
  12. Schaub RT, Munzberg H, Borchelt M, Nieczaj R, Hillen T, Reischies FM, Schlattmann P, Geiselmann B, Steinhagen-Theissen E. Ventilatory capacity and risk for dementia. J Gerontol 2000;55A:M677–83.
  13. Hole DJ, Watt GCM, Davey Smith G, Hart CL, Gillis CR, Hawthorne VM. Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley Prospective population study. BMJ 1996;313:711–6.[Abstract/Free Full Text]
  14. Whalley LJ, Deary IJ. Longitudinal cohort study of childhood IQ and survival up to age 76. BMJ 2001;322:1–5.[Abstract/Free Full Text]
  15. Liao D, Higgins M, Bryan NR, Eigenbrodt ML, Chambless LE, Lamar V, Burke GL, Heiss G. Lower pulmonary function and cerebral subclinical abnormalities detected by MRI: the Atherosclerosis Risk in Communities study. Chest 1999;116:150–6.[Abstract/Free Full Text]
  16. Gibson GE, Pulsinelli W, Blass JP, Duffy TE. Brain dysfunction in mild to moderate hypoxia. Am J Med 1981;70:1247–54.[CrossRef][Medline]
  17. Harper RM. The cerebral regulation of cardiovascular and respiratory functions. Semin Pediatr Neurol 1996;3:13–22.[CrossRef][Medline]
  18. Wadsworth MEJ. The Imprint of Time: Childhood, History and Adult Life. Oxford: Clarendon Press; 1991.
  19. Wadsworth MEJ, Butterworth SL, Hardy R, Kuh D, Richards M, Langenberg C, Connor M. The life course design: an example of benefits and problems associated with study longevity. Soc Sci Med 2003;57:2193–205.
  20. Nelson HE, Willison JR. National Adult Reading Test (NART), 2nd ed. Windsor, UK: NFER-Nelson; 1991.
  21. Strachan DP, Griffiths JM, Anderson HR, Johnston IDA. Association of intrauterine and postnatal growth with ventilatory function in early adult life. Thorax 1994;49:1052P.
  22. Richards M, Hardy R, Kuh D, Wadsworth M. Birthweight and cognitive function in the British 1946 birth cohort. BMJ 2001;322:199–202.[Abstract/Free Full Text]
  23. Richards M, Hardy R, Kuh D, Wadsworth M. Postnatal growth and cognitive function in a national UK birth cohort. Int J Epidemiol 2002;31:342–8.[Abstract/Free Full Text]
  24. Richards M, Wadsworth MEJ. Long term effects of early adversity on cognitive function. Arch Dis Child 2004;89:922–7.[Abstract/Free Full Text]
  25. Richards M, Jarvis M, Thompson N, Wadsworth M. Cigarette smoking and cognitive decline in midlife: longitudinal population based study. Am J Public Health 2003;93:994–8.[Abstract/Free Full Text]
  26. Richards M, Hardy R, Wadsworth M. Does active leisure protect cognition? Evidence from a national birth cohort. Soc Sci Med 2003;56:785–92.
  27. Kuh D, Cooper C. Physical activity at 36 years: patterns and childhood predictors in a longitudinal study. J Epidemiol Community Health 1992;46:114–9.[Abstract/Free Full Text]
  28. Rodgers B. Pathways between parental divorce and adult depression. J Child Psychol Psychiatry 1994;35:1289–308.[Medline]
  29. Britten N, Davies JMC, Colley JRT. Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. BMJ 1987;294:1317–20.
  30. Mann SL, Wadsworth MEJ, Colley JRT. Accumulation of factors influencing respiratory illness in members of a national birth cohort and their offspring. J Epidemiol Community Health 1992;46:286–92.[Abstract/Free Full Text]
  31. Douglas JWB, Waller RE. Air pollution and respiratory infection in children. Br J Prev Soc Med 1966;20:1–8.
  32. Heim AW. The AH4 Group Test of Intelligence. Windsor, UK: NFER-Nelson; 1970.
  33. Pigeon DA. Details of the fifteen years tests. In: Douglas JWB, Ross JM, Simpson HR, eds. All Our Future. London: Davies; 1968:appendix 1.
  34. Schunemann HJ, McCann S, Grant BJB, Trevisan M, Muti P, Freudenheim JL. Lung function in relation to intake of carotenoids and other antioxidant vitamins in a population-based study. Am J Epidemiol 2002;155:463–71.[Abstract/Free Full Text]
  35. Astrund P-O, Rodhal K. Textbook of work physiology. Physiological Bases of Exercise, 3rd ed. McGraw-Hill Book Co; 1986.
  36. McArdle WD, Katch FI, Katch VL. Essentials of Exercise Physiology. Baltimore: Lippincott Williams & Wilkins; 1968.
  37. Santiago TV, Deelman NH. Brain blood flow and control of breathing. In: Fishman AP, Cherniak NS, Widdicombe JG, Geiger SR, eds. The Handbook of Physiology, Section 3: The Respiratory System. Bethesda, MD: American Physiological Society; 1986:163–79.
  38. Longstreth WT, Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, Enright PL, O’Leary D, Fried L. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274–82.[Abstract/Free Full Text]
  39. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–22.[Abstract/Free Full Text]
  40. Kannel WB, Dawber TR, Sorlie P, Wolf PA. Components of blood pressure and risk for atheroembolic brain infarction. The Framingham Study. Stroke 1976;7:327–33.[Abstract/Free Full Text]
  41. Christensen H, Mackinnon AJ, Korten A, Jorm AF. The ‘common cause hypothesis’ of cognitive aging: evidence for not only a common factor but also specific associations of age with vision and grip strength in a cross-sectional study. Psychol Aging 2001;16:588–99.[CrossRef][Medline]
  42. Strachan DP. Respiratory and allergic diseases. In: Kuh D, Ben Shlomo Y, eds. A Life Course Approach to Chronic Disease Epidemiology. Oxford: Oxford University Press; 1997:101–20.
  43. Richards M, Sacker A. Lifetime antecedents of cognitive reserve. J Clin Exp Neuropsychol 2003;25:614–24.[Medline]
  44. Dempsey JA, Olson EB, Skatrud JB. Hormones and neurochemicals in the regulation of breathing. In: Fishman AP, Cherniak NS, Widdicombe JG, Geiger SR, eds. The Handbook of Physiology, Section 3: The Respiratory System. Bethesda, MD: American Physiological Society; 1986:181–221.
  45. Seckl JR. Glucocorticoids, feto-placental 11ß-hydroxysteroid dehydrogenase type 2, and the early life origins of adult disease. Steroids 1997;62:89–94.[CrossRef][Medline]
  46. Sapolsky RM, Krey LC, McEwen BS. The neuroendocrinology of stress and aging—the glucocorticoid cascade hypothesis. Endocr Rev 1986;7:284–301.[Abstract/Free Full Text]
  47. Price WA, Stiles AD, Moats-Staats BM, D’Ercole AJ. Gene expression of the insulin-like growth factors (IGFs), the type 1 IGF receptor, and IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology 1992;130:1424–32.[Abstract/Free Full Text]
  48. Li J, Saunders JC, Gilmore RS, Fowden AL. Insulin-like growth factor-II messenger RNA expression in fetal tissues of the sheep during late gestation: effects of cortisol. Endocrinology 1993;132:2083–9.[Abstract/Free Full Text]
  49. Berger A. Insulin-like growth factor and cognitive function. BMJ 2001;322:203.[Free Full Text]



This article has been cited by other articles:


Home page
Psychosom. Med.Home page
E. J. Giltay, A. Nissinen, S. Giampaoli, F. G. Zitman, and D. Kromhout
Low Respiratory Function Increases the Risk of Depressive Symptoms in Later Life in Men
Psychosom Med, January 1, 2010; 72(1): 53 - 60.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
W. W. Hung, J. P. Wisnivesky, A. L. Siu, and J. S. Ross
Cognitive Decline among Patients with Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 134 - 137.
[Abstract] [Full Text] [PDF]


Home page
J. Epidemiol. Community HealthHome page
S Clennell, D Kuh, J M Guralnik, K V Patel, and G D Mishra
Characterisation of smoking behaviour across the life course and its impact on decline in lung function and all-cause mortality: evidence from a British birth cohort
J Epidemiol Community Health, December 1, 2008; 62(12): 1051 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
L Orfei, D P Strachan, A R Rudnicka, and M E J Wadsworth
Early influences on adult lung function in two national British cohorts
Arch. Dis. Child., July 1, 2008; 93(7): 570 - 574.
[Abstract] [Full Text] [PDF]


Home page
Psychosom. Med.Home page
S. F. Suglia, R. O. Wright, J. Schwartz, and R. J. Wright
Association Between Lung Function and Cognition Among Children in a Prospective Birth Cohort Study
Psychosom Med, April 1, 2008; 70(3): 356 - 362.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. J. Deary, L. J. Whalley, G. D. Batty, and J. M. Starr
Physical fitness and lifetime cognitive change.
Neurology, October 10, 2006; 67(7): 1195 - 1200.
[Abstract] [Full Text] [PDF]


Home page
Int J EpidemiolHome page
M. Wadsworth, D. Kuh, M. Richards, and R. Hardy
Cohort Profile: The 1946 National Birth Cohort (MRC National Survey of Health and Development)
Int. J. Epidemiol., February 1, 2006; 35(1): 49 - 54.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richards, M.
Right arrow Articles by Wadsworth, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richards, M.
Right arrow Articles by Wadsworth, M.
Related Collections
Right arrow Pulmonary
Right arrow Cognitive Functioning


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS